Excessive exogenous thyroid hormone ingestion may lead to severe thyrotoxicosis and cause potential harm; this review of the literature suggests that thyroid hormone supplementation should not be used to alleviate nonspecific complaints in patients with normal endogenous thyroid function.
This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.
This review discusses levothyroxine therapy in the alleviation of hypothyroidism, focusing on complex needs, the available options and setpoints.
Hypoglycaemia is a frequent complication of insulin
therapy. Injectable glucagon and oral intake of carbohydrates are
the recommended treatments for severe and non-severe
hypoglycaemic episodes, respectively. New uses and formulations of glucagon are reviewed and discussed in this article.
Menopause hormone therapy still remains a dominant
therapeutic modality in climacteric medicine. The core medical
skill is the ability to choose the optimal MHT preparation for
the given patient. Such choice is based on an understanding of
various clinical and metabolic effects of MHT depending on the
composition, dosage, and the method of application, this article discusses those choices.
